MINT-APIXABAN
MINT-APIXABAN
Approved
DIN Number
02495449
Drug Class
Human
Market Date
Oct 28, 2022
Company
HC
mint pharmaceuticals inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02495449
AIG Number0153051002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AF02 APIXABAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
Health Canada Classification
ACTIVE INGREDIENTS (1)
APIXABANActive
Strength: 5 MG
Monograph: APIXABAN